If the left wants to build a mass movement that appeals to millions, we first have to address the tiny, vocal minority in our ranks holding all of us back.
pharmaceutical research
Follow:
-
Martin Shkreli Is An Example Of Why We Need Publicly Funded Pharmaceutical Research
Facing national outrage, the 32-year-old CEO backed down from the 5000% price increase his company announced this week for the malaria and toxoplasmosis drug Daraprim, sparking an overdue debate about the outlandish cost of life-saving medicines.
